Vol. 52, No. 1, Jul. 2024
Cornerstone of next generation research and development: Overcoming COVID-19 pandemic /
For the 2024 revision of the Declaration of Helsinki: From the “Ethical innovation for global health”
 
Contents
 
●EditorialKurihara C 4-7Full text
 
●Cornerstone of next generation research and development: Overcoming COVID-19 pandemic
・Articles
　Promotion of the Utilization of Real-World Data
　　under the Revised Next Generation Medical Infrastructure Act		Yshihara H，Anan K9-22 Abstract
　The role of telemedicine in end-of-life care for the elderly Sakai M，Uchida T23-7Full text
　Results of a career survey of physicians and PhD researchers
　　with 10 years or longer tenure in the pharmaceutical industry 		Tamada H，Maeda-Chubachi T，
Mukai H，et al．		29-42 Abstract
　Points to note when interpreting on Excess Deaths presented
　　by the National Institute of Infectious Diseases in Japan		Suzumura Y43-58 Full text
　Editor’s note to Suzumura’s article “Points to note
　　when interpreting on Excess Deaths presented
　　　by the National Institute of Infectious Diseases in Japan”		Kurihara C59-61 Full text
・Translation and explanatory article
　Unveiling Excess Mortality: How to know the fact as it isFukushima M 63-4Full text
　Increased age-adjusted cancer mortality
　　after the third mRNA-lipid nanoparticle vaccine dose
　　　during the COVID-19 pandemic in Japan		Gibo M，Kojima S，Fujisawa A，et al．
（Translated and supervised by Gibo M
　Supervised by Kojima S，Fujisawa A，
 　　　　　　　　Kikuchi T，Fukushima M
　Translated by Hirai Y）		 65-90Full text
 
●For the 2024 revision of the Declaration of Helsinki: From the “Ethical innovation for global health”
　Our “WMA Declaration of Helsinki”
　　－Opinions and proposals from patient and public－		Kurihara C，Inoue K，Kai H，et al． 91-131Full text
　Ethics of placebo-controlled trials: Historical analysis
　　including experiences during the COVID-19 pandemic		Kurihara C，Greco D，Dhai A，et al．
（Trans. by Kurihara C，Saio T）		133-59 Full text
　Post-trial access: Historical analysis
　　considering the experience of COVID-19 pandemic		Kurihara C，Greco D，Dhai A
（Trans. by Kurihara C）		161-77 Full text
 
●Instructions for authors［Japanese］＆［English］ 179-87Full text
 
●Editor’s noteImamura K 189Full text

Retraction unexplained: On the incomprehensive retraction by Cureus Editorial Board of
“Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose
During the COVID-19 Pandemic in Japan”, a Japanese translation of which was published
in Clinical Evaluation Vol. 52, No. 1.

Back to Rinsho Hyoka(Clinical Evaluation) home page
Back to Contents